The Role of SGLT-2 Inhibitors in Type 2 Diabetes

Mrmed.in07 Oct, 2023Health

Type 2 diabetes mellitus (T2DM), a chronic metabolic condition, is distinguished by high blood sugar and insulin resistance. One significant advancement in the treatment of T2DM over the years is the creation of sodium-glucose cotransporter-2 (SGLT-2) inhibitors. The sodium-glucose cotransporter-2 proteins in the kidneys are the target of a class of oral diabetic medications known as SGLT-2 inhibitors.

Recent Profiles

Reno Con

Reno Con

View Profile

REDCODE EHS

Redcode Ehs

View Profile

Okking1

Okking1

View Profile

Future Digital Studio

Future Digital Studio

View Profile

king98

King98

View Profile

Koitoto Situs Slot88

Koitoto Situs Slot88

View Profile

Fly88

Fly88

View Profile

Elaine Allie

Elaine Allie

View Profile

Novus Loyalty

Novus Loyalty

View Profile

mapquest

Mapquest

View Profile